Pirenoxine

Pirenoxine

Clinical data
Trade names	Catalin
ATCvet code	Template:Infobox drug/formatATCvet Template:Infobox drug/formatATCvet
Identifiers
IUPAC name 1,5-Dioxo-4H-pyrido[3,2-a]phenoxazine-3-carboxylic acid
CAS Number	1043-21-6
PubChem CID	4846
ChemSpider	4846
UNII	27L0EP6IZK
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C16H8N2O5
Molar mass	308.24512 g/mol
3D model (JSmol)	Interactive image
SMILES C1=CC=C2C(=C1)N=C3C(=CC(=O)C4=C3C(=O)C=C(N4)C(=O)O)O2
InChI InChI=1S/C16H8N2O5/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12/h1-6H,(H,18,19)(H,21,22) Key:OKPNYGAWTYOBFZ-UHFFFAOYSA-N

WikiDoc Resources for Pirenoxine
Articles
Most recent articles on Pirenoxine Most cited articles on Pirenoxine Review articles on Pirenoxine Articles on Pirenoxine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Pirenoxine Images of Pirenoxine Photos of Pirenoxine Podcasts & MP3s on Pirenoxine Videos on Pirenoxine
Evidence Based Medicine
Cochrane Collaboration on Pirenoxine Bandolier on Pirenoxine TRIP on Pirenoxine
Clinical Trials
Ongoing Trials on Pirenoxine at Clinical Trials.gov Trial results on Pirenoxine Clinical Trials on Pirenoxine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Pirenoxine NICE Guidance on Pirenoxine NHS PRODIGY Guidance FDA on Pirenoxine CDC on Pirenoxine
Books
Books on Pirenoxine
News
Pirenoxine in the news Be alerted to news on Pirenoxine News trends on Pirenoxine
Commentary
Blogs on Pirenoxine
Definitions
Definitions of Pirenoxine
Patient Resources / Community
Patient resources on Pirenoxine Discussion groups on Pirenoxine Patient Handouts on Pirenoxine Directions to Hospitals Treating Pirenoxine Risk calculators and risk factors for Pirenoxine
Healthcare Provider Resources
Symptoms of Pirenoxine Causes & Risk Factors for Pirenoxine Diagnostic studies for Pirenoxine Treatment of Pirenoxine
Continuing Medical Education (CME)
CME Programs on Pirenoxine
International
Pirenoxine en Espanol Pirenoxine en Francais
Business
Pirenoxine in the Marketplace Patents on Pirenoxine
Experimental / Informatics
List of terms related to Pirenoxine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pirenoxine (abbreviated PRX, trade name Catalin) is a medication used in the possible treatment and prevention of cataracts. A report in the journal of Inorganic Chemistry showed that in liquid solutions pirenoxine could cause decreased cloudiness of a crystallin solution produced to mimic the environment of the eye. Pirenoxine interacts with selenite or calcium ions that have been proven as factors leading to the formation of lens cataract.

Pirenoxine reduces the cloudiness of the lens solution containing calcium by 38% and reduced the cloudiness of the selenite solution by 11%.